IBDEI14D ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18160,1,4,0)
 ;;=4^E11.44
 ;;^UTILITY(U,$J,358.3,18160,2)
 ;;=^5002648
 ;;^UTILITY(U,$J,358.3,18161,0)
 ;;=E11.49^^61^805^8
 ;;^UTILITY(U,$J,358.3,18161,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18161,1,3,0)
 ;;=3^DM Type 2 w/ Diab Neurological Compl
 ;;^UTILITY(U,$J,358.3,18161,1,4,0)
 ;;=4^E11.49
 ;;^UTILITY(U,$J,358.3,18161,2)
 ;;=^5002649
 ;;^UTILITY(U,$J,358.3,18162,0)
 ;;=E11.59^^61^805^25
 ;;^UTILITY(U,$J,358.3,18162,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18162,1,3,0)
 ;;=3^DM Type 2 w/ Oth Circulatory Compl
 ;;^UTILITY(U,$J,358.3,18162,1,4,0)
 ;;=4^E11.59
 ;;^UTILITY(U,$J,358.3,18162,2)
 ;;=^5002652
 ;;^UTILITY(U,$J,358.3,18163,0)
 ;;=E11.610^^61^805^9
 ;;^UTILITY(U,$J,358.3,18163,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18163,1,3,0)
 ;;=3^DM Type 2 w/ Diab Neuropathic Arthropathy
 ;;^UTILITY(U,$J,358.3,18163,1,4,0)
 ;;=4^E11.610
 ;;^UTILITY(U,$J,358.3,18163,2)
 ;;=^5002653
 ;;^UTILITY(U,$J,358.3,18164,0)
 ;;=E11.618^^61^805^26
 ;;^UTILITY(U,$J,358.3,18164,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18164,1,3,0)
 ;;=3^DM Type 2 w/ Oth Diab Arthropathy
 ;;^UTILITY(U,$J,358.3,18164,1,4,0)
 ;;=4^E11.618
 ;;^UTILITY(U,$J,358.3,18164,2)
 ;;=^5002654
 ;;^UTILITY(U,$J,358.3,18165,0)
 ;;=E11.621^^61^805^16
 ;;^UTILITY(U,$J,358.3,18165,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18165,1,3,0)
 ;;=3^DM Type 2 w/ Foot Ulcer
 ;;^UTILITY(U,$J,358.3,18165,1,4,0)
 ;;=4^E11.621
 ;;^UTILITY(U,$J,358.3,18165,2)
 ;;=^5002656
 ;;^UTILITY(U,$J,358.3,18166,0)
 ;;=E11.622^^61^805^31
 ;;^UTILITY(U,$J,358.3,18166,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18166,1,3,0)
 ;;=3^DM Type 2 w/ Oth Skin Ulcer
 ;;^UTILITY(U,$J,358.3,18166,1,4,0)
 ;;=4^E11.622
 ;;^UTILITY(U,$J,358.3,18166,2)
 ;;=^5002657
 ;;^UTILITY(U,$J,358.3,18167,0)
 ;;=E11.628^^61^805^30
 ;;^UTILITY(U,$J,358.3,18167,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18167,1,3,0)
 ;;=3^DM Type 2 w/ Oth Skin Compl
 ;;^UTILITY(U,$J,358.3,18167,1,4,0)
 ;;=4^E11.628
 ;;^UTILITY(U,$J,358.3,18167,2)
 ;;=^5002658
 ;;^UTILITY(U,$J,358.3,18168,0)
 ;;=E11.630^^61^805^33
 ;;^UTILITY(U,$J,358.3,18168,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18168,1,3,0)
 ;;=3^DM Type 2 w/ Periodontal Disease
 ;;^UTILITY(U,$J,358.3,18168,1,4,0)
 ;;=4^E11.630
 ;;^UTILITY(U,$J,358.3,18168,2)
 ;;=^5002659
 ;;^UTILITY(U,$J,358.3,18169,0)
 ;;=E11.638^^61^805^29
 ;;^UTILITY(U,$J,358.3,18169,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18169,1,3,0)
 ;;=3^DM Type 2 w/ Oth Oral Compl
 ;;^UTILITY(U,$J,358.3,18169,1,4,0)
 ;;=4^E11.638
 ;;^UTILITY(U,$J,358.3,18169,2)
 ;;=^5002660
 ;;^UTILITY(U,$J,358.3,18170,0)
 ;;=E11.641^^61^805^20
 ;;^UTILITY(U,$J,358.3,18170,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18170,1,3,0)
 ;;=3^DM Type 2 w/ Hypoglycemia w/ Coma
 ;;^UTILITY(U,$J,358.3,18170,1,4,0)
 ;;=4^E11.641
 ;;^UTILITY(U,$J,358.3,18170,2)
 ;;=^5002661
 ;;^UTILITY(U,$J,358.3,18171,0)
 ;;=E11.649^^61^805^21
 ;;^UTILITY(U,$J,358.3,18171,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18171,1,3,0)
 ;;=3^DM Type 2 w/ Hypoglycemia w/o Coma
 ;;^UTILITY(U,$J,358.3,18171,1,4,0)
 ;;=4^E11.649
 ;;^UTILITY(U,$J,358.3,18171,2)
 ;;=^5002662
 ;;^UTILITY(U,$J,358.3,18172,0)
 ;;=E11.65^^61^805^17
 ;;^UTILITY(U,$J,358.3,18172,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18172,1,3,0)
 ;;=3^DM Type 2 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,18172,1,4,0)
 ;;=4^E11.65
 ;;^UTILITY(U,$J,358.3,18172,2)
 ;;=^5002663
